Physician profile
David A Calef
NPI 1215067913
$1,339.60
in general payments reported to CMS, 2019-2025
20 companies · $43.37 in 2025
The $43.37 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,023 · 2020: $221 · 2021: $16.81 · 2023: $35.45 · 2025: $43.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $454.22 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $252.45 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $90.70 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $85.23 | 2019 | |
| Glaxosmithkline, LLC. | $77.90 | 2019-2021 | |
| Horizon Therapeutics Plc | $62.82 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.79 | 2019 | |
| Amgen INC. | $37.90 | 2019 | |
| Astellas Pharma US INC | $35.90 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $29.57 | 2019 | |
| Sanofi Pasteur INC. | $21.50 | 2020 | |
| Amarin Pharma, INC. | $18.86 | 2020 | |
| Scilex Pharmaceuticals INC. | $18.67 | 2019 | |
| Janssen Pharmaceuticals, INC | $18.45 | 2019 | |
| Shire North American Group INC | $17.69 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $17.03 | 2020 | |
| Seqirus USA INC | $16.98 | 2020 | |
| Shionogi INC | $16.31 | 2019 | |
| Allergan, INC. | $14.02 | 2019 | |
| Lilly USA, LLC | $12.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Calef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.